Related Experiment Videos
DNA modification of bacteriophage Mu-1 requires both host and bacteriophage functions
Journal of Virology
|September 1, 1977
Abstract:
It was previously shown that resistance of phage Mu-1 to several restriction enzymes is due to a modification function (called mom) encoded by the phage. More recent studies emphasized that modification of Mu requires not only an active mom function, but also an active dam function supplied by the Escherichia coli host.
Insights
Phage Mu-1 resistance to restriction enzymes relies on its mom function. However, effective modification also necessitates the host Escherichia coli's dam function for complete phage protection.
Area of Science:
- Molecular Biology
- Virology
- Bacteriology
Background:
- Phage Mu-1 exhibits resistance to multiple restriction enzymes.
- This resistance was previously attributed to a phage-encoded modification function, termed 'mom'.
- Previous research indicated the 'mom' function is crucial for phage resistance.
Purpose of the Study:
- To investigate the complete requirements for phage Mu-1 modification.
- To elucidate the role of host factors in phage resistance.
- To understand the interplay between phage and host genetic elements in modification.
Main Methods:
- Analysis of phage-host interactions.
- Genetic studies involving phage Mu-1 and Escherichia coli.
- Enzyme restriction assays to assess phage modification.
Main Results:
- Phage Mu-1 modification requires both the phage-encoded 'mom' function and the host-supplied 'dam' function.
- The 'dam' function from Escherichia coli is essential for complete modification of phage Mu-1.
- The combined action of 'mom' and 'dam' functions confers resistance to restriction enzymes.
Conclusions:
- Phage resistance in Mu-1 is a collaborative process involving both phage and host genetic machinery.
- The 'dam' function of Escherichia coli plays a critical, previously unemphasized role in Mu-1 modification.
- Understanding these interactions is key to comprehending phage-host dynamics and developing novel antiviral strategies.